In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Alprazolam XR is indicated for the treatment of panic disorder with or without agoraphobia, in adults.
Administer Alprazolam XR orally once daily, preferably in the morning. Swallow tablets whole; do not divide, crush...
Alprazolam XR extended-release tablets are available as:
Alprazolam XR is contraindicated in patients:
Concomitant use of benzodiazepines, including Alprazolam XR, and opioids may result in profound...
The following clinically significant adverse reactions are described elsewhere in the labeling:
Table 4 includes clinically significant drug interactions with Alprazolam XR...
Pregnancy Exposure Registry
Alprazolam XR contains alprazolam, which is a Schedule IV controlled substance.
Manifestations of alprazolam overdosage include somnolence, confusion, impaired coordination, diminished reflexes, and coma....
Alprazolam XR contains alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds.
The chemical name of alprazolam is 8-chloro-1-methyl-6-phenyl-4...
Alprazolam is a 1,4 benzodiazepine. Alprazolam exerts its effect for the treatment of panic disorder through binding...
The efficacy of Alprazolam XR in the treatment of panic disorder in adults was established in two 6-week, flexible-dose, placebo-controlled studies in adult patients meeting DSM-III criteria for panic...
Alprazolam XR is supplied in the following strengths and package configurations:
This product's labeling may have been updated. For the most recent prescribing information, please visit www.greenstonellc.com.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.